In a study, IP injection of human papillomavirus 16 (HPV 16) pseudovirion to deliver the herpes simplex virus thymidine kinase (HSV-TK) gene to ovarian tumour cells was able to preferentially infect murine and human ovarian tumour cells in tumour-bearing nude mice. This evidence concerns the gene TKT and ovarian neoplasm.